Back to Search Start Over

Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care:characteristics and predictors

Authors :
Terslev, L.
Ostergaard, Mikkel
Georgiadis, Stylianos
Brahe, Cecilie Heegaard
Ellegaard, Karen
Dohn, U. M.
Fana, Viktoria
Møller, Torsten
Juul, Lars
Huynh, Tuan Khai
Krabbe, Simon
Ornbjerg, L. M.
Glinatsi, Daniel
Røgind, Henrik
Hansen, Annette
Nørregaard, Jesper
Jacobsen, Søren
Jensen, Dorte V.
Manilo, Natalia
Asmussen, Karsten
Boesen, Mikael
Rastiemadabadi, Zoreh
Morsel-Carlsen, Lone
Møller, Jakob Møllenbach
Krogh, Niels Steen
Hetland, Merete Lund
Terslev, L.
Ostergaard, Mikkel
Georgiadis, Stylianos
Brahe, Cecilie Heegaard
Ellegaard, Karen
Dohn, U. M.
Fana, Viktoria
Møller, Torsten
Juul, Lars
Huynh, Tuan Khai
Krabbe, Simon
Ornbjerg, L. M.
Glinatsi, Daniel
Røgind, Henrik
Hansen, Annette
Nørregaard, Jesper
Jacobsen, Søren
Jensen, Dorte V.
Manilo, Natalia
Asmussen, Karsten
Boesen, Mikael
Rastiemadabadi, Zoreh
Morsel-Carlsen, Lone
Møller, Jakob Møllenbach
Krogh, Niels Steen
Hetland, Merete Lund
Source :
Terslev , L , Ostergaard , M , Georgiadis , S , Brahe , C H , Ellegaard , K , Dohn , U M , Fana , V , Møller , T , Juul , L , Huynh , T K , Krabbe , S , Ornbjerg , L M , Glinatsi , D , Røgind , H , Hansen , A , Nørregaard , J , Jacobsen , S , Jensen , D V , Manilo , N , Asmussen , K , Boesen , M , Rastiemadabadi , Z , Morsel-Carlsen , L , Møller , J M , Krogh , N S & Hetland , M L 2022 , ' Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care : characteristics and predictors ' , RMD Open , vol. 8 , no. 2 .
Publication Year :
2022

Abstract

OBJECTIVE: To identify predictors of flare in a 2-year follow-up study of patients with rheumatoid arthritis (RA) in sustained clinical remission tapering towards withdrawal of biological disease-modifying anti-rheumatic drugs (bDMARDs). METHODS: Sustained clinical remission was defined as Disease Activity Score for 28 joints (DAS28)-C reactive protein (CRP) ≤2.6 without radiographic progression for >1 year. bDMARDs were tapered according to a mandatory clinical guideline to two-thirds of standard dose at baseline, half of dose at week 16 and discontinuation at week 32. Prospective assessments for 2 years included clinical evaluation, conventional radiography, ultrasound and MRI for signs of inflammation and bone changes. Flare was defined as DAS28-CRP ≥2.6 with ∆DAS28-CRP ≥1.2 from baseline. Baseline predictors of flare were assessed by logistic regression analyses. RESULTS: Of 142 included patients, 121 (85%) flared during follow-up of which 86% regained remission within 24 weeks after flare. Patients that flared were more often rheumatoid factor positive, had tried more bDMARDs and had higher baseline ultrasound synovitis sum scores than those not flaring. For patients on standard dose, predictors of flare within 16 weeks after reduction to two-thirds of standard dose were baseline MRI-osteitis (OR 1.16; 95% CI 1.03 to 1.33; p=0.014), gender (female) (OR 6.71; 95% CI 1.68 to 46.12; p=0.005) and disease duration (OR 1.06; 95% CI 1.01 to 1.11; p=0.020). Baseline predictors for flare within 2 years were ultrasound grey scale synovitis sum score (OR 1.19; 95% CI 1.02 to 1.44; p=0.020) and number of previous bDMARDs (OR 4.07; 95% CI 1.35 to 24.72; p=0.007). CONCLUSION: The majority of real-world patients with RA tapering bDMARDs flared during tapering, with the majority regaining remission after stepwise dose increase. Demographic and imaging parameters (MR-osteitis/ultrasound greyscale synovitis) were independent predictors of immediate flare and flare overall

Details

Database :
OAIster
Journal :
Terslev , L , Ostergaard , M , Georgiadis , S , Brahe , C H , Ellegaard , K , Dohn , U M , Fana , V , Møller , T , Juul , L , Huynh , T K , Krabbe , S , Ornbjerg , L M , Glinatsi , D , Røgind , H , Hansen , A , Nørregaard , J , Jacobsen , S , Jensen , D V , Manilo , N , Asmussen , K , Boesen , M , Rastiemadabadi , Z , Morsel-Carlsen , L , Møller , J M , Krogh , N S & Hetland , M L 2022 , ' Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care : characteristics and predictors ' , RMD Open , vol. 8 , no. 2 .
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1382518664
Document Type :
Electronic Resource